Despite extensive studies over many years, the molecular and biochemical mechanisms of insulin action remain to be elucidated. The first step in this mechanism is the binding of insulin to a specific receptor on the plasma membrane of target cells. Analysis of the structure and function of the insulin receptor (IR) is hampered by the fact that all cells tested have detectable levels of endogenous IRs. We propose to take a novel approach by using homologousrecombination, following microinjection of mutated genomic DNA fragments, to inactivate the endogenous IR genes. Specifically, both single and double allele mutants will be produced in HepG2 hepatoma, and 3T3-F442A adipocyte cell lines. The single allele mutants will be used for studies involving the regulation of individual alleles, the double allele mutants, which will be receptor null cells, will be used for transfection studies with mutant IRs generated by in vivo site-directed mutagenesis. Furthermore, we will make functional mutations by in vivo mutagenesis, in one allele only to study, the interaction between IRs in a heterozygote cell as a model for NIDDM.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
1R01DK044643-01A1
Application #
3246179
Study Section
Metabolism Study Section (MET)
Project Start
1992-09-30
Project End
1995-09-29
Budget Start
1992-09-30
Budget End
1993-09-29
Support Year
1
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093